300485 賽升藥業
按盤價 
9.700 +1.510 (+18.437%)
9.700 +1.510 (+18.437%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.138 | 0.433 | -2.027 | 3.023 | 6.187 |
| 總資產報酬率 ROA (%) | 0.131 | 0.409 | -1.920 | 2.862 | 5.874 |
| 投入資產回報率 ROIC (%) | 0.134 | 0.421 | -1.970 | 2.936 | 6.064 | 邊際利潤分析 |
| 銷售毛利率 (%) | 68.106 | 65.115 | 66.282 | 70.426 | 76.638 |
| 營業利潤率 (%) | 4.090 | 3.068 | -19.923 | 25.544 | 34.666 |
| 息稅前利潤/營業總收入 (%) | 4.944 | 2.829 | -20.470 | 25.414 | 34.602 |
| 淨利潤/營業總收入 (%) | 4.219 | 1.925 | -18.458 | 20.230 | 27.588 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 196.871 | -96.322 | -30.401 | -33.626 | 9.430 |
| 價值變動淨收益/利潤總額(%) | -137.270 | 301.910 | 129.395 | 131.033 | 83.309 |
| 營業外收支淨額/利潤總額(%) | 16.731 | -0.914 | 0.709 | 0.349 | -0.008 | 償債能力分析 |
| 流動比率 (X) | 20.089 | 18.284 | 20.860 | 26.300 | 17.621 |
| 速動比率 (X) | 19.268 | 17.538 | 19.868 | 24.219 | 16.432 |
| 資產負債率 (%) | 4.764 | 4.931 | 4.687 | 4.268 | 4.402 |
| 帶息債務/全部投入資本 (%) | 0.753 | 0.687 | 0.108 | 0.172 | 0.253 |
| 股東權益/帶息債務 (%) | 12,856.403 | 14,110.891 | 90,494.815 | 56,495.613 | 38,469.304 |
| 股東權益/負債合計 (%) | 1,986.892 | 1,915.832 | 2,016.513 | 2,222.370 | 2,147.677 |
| 利息保障倍數 (X) | 154.837 | -13.433 | 50.480 | -115.483 | -563.178 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.465 | 39.903 | 40.744 | 46.431 | 40.964 |
| 存貨周轉天數 (天) | 219.059 | 191.516 | 241.526 | 250.518 | 222.522 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 23/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
